Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anthracyclines-Induced Cardiotoxicity”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Testing effectiveness (Phase 2)UnknownNCT03785704
What this trial is testing

Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast NeoplasmsCardiac EventChemotherapeutic Toxicity
Peking Union Medical College 60
Not applicableEnded earlyNCT00679874
What this trial is testing

Assessment of Cardiotoxicity After Chemotherapy for Breast Cancer by Cardio-vascular Magnetic Resonance (MR)

Who this might be right for
Breast Cancer
University of Calgary 66
Not applicableStudy completedNCT01212926
What this trial is testing

Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D Strain

Who this might be right for
LeukemiaCardiac Toxicity
University Hospital, Bordeaux 100
Testing effectiveness (Phase 2)Looking for participantsNCT05732051
What this trial is testing

Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Breast CancerMetastatic Breast CancerCancer Therapy-Related Cardiac Dysfunction+2 more
University Hospital, Akershus 60
Not applicableLooking for participantsNCT06443645
What this trial is testing

Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-B

Who this might be right for
Breast Neoplasms
Centre Paul Strauss 50
Not applicableUnknownNCT04461223
What this trial is testing

Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR

Who this might be right for
CardiotoxicityOsteosarcomaMyocardial Injury+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 55
Not applicableStudy completedNCT05923242
What this trial is testing

Translating ECHOS2 Into an mHealth Platform

Who this might be right for
Childhood CancerCardiac ToxicityPediatric Cancer
Washington University School of Medicine 73
Not applicableNot Yet RecruitingNCT06881940
What this trial is testing

Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab

Who this might be right for
Cancer Therapy-Related Cardiac Dysfunction
Instituto Nacional de Cardiologia Ignacio Chavez 284
Not applicableEnrolling By InvitationNCT01173341
What this trial is testing

Cardiotoxicity of Cancer Therapy (CCT)

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 700
Large-scale testing (Phase 3)Ended earlyNCT00247975
What this trial is testing

Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

Who this might be right for
Heart Failure
Ottawa Heart Institute Research Corporation 36
Post-approval studies (Phase 4)UnknownNCT06005259
What this trial is testing

Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)

Who this might be right for
CardiotoxicityNeoplasmsChemotherapy Effect+1 more
University of Sao Paulo 264
Not applicableStudy completedNCT03940625
What this trial is testing

Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mapping

Who this might be right for
Breast CancerMyocardial DamageCardiotoxicity
Heinrich-Heine University, Duesseldorf 69
Not applicableLooking for participantsNCT03790943
What this trial is testing

Cardiac Dysfunction in Childhood Cancer Survivors

Who this might be right for
Cardiac DysfunctionCardiovascular DiseasesChildhood Cancer
University of Bern 500
Not applicableStudy completedNCT02065908
What this trial is testing

Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer

Who this might be right for
Breast Cancer
West Pomeranian Cancer Center 128
Not applicableUnknownNCT02471885
What this trial is testing

Effect of Remote Ischaemic Conditioning in Oncology Patients

Who this might be right for
Cardiotoxicity
University College, London 128
Not applicableStudy completedNCT02916316
What this trial is testing

Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell

Who this might be right for
LymphomaLarge B-CellDiffuse Large B-Cell
Fondazione Italiana Linfomi - ETS 127
Large-scale testing (Phase 3)UnknownNCT04030546
What this trial is testing

Ivabradine to Prevent Anthracycline-induced Cardiotoxicity

Who this might be right for
Patients With Cancer
Vilnius University 128
Not applicableStudy completedNCT03964142
What this trial is testing

Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced Cardiotoxicity

Who this might be right for
CardiotoxicityCardiac Rehabilitation
Hospital Clinico Universitario de Santiago 122
Post-approval studies (Phase 4)UnknownNCT04939883
What this trial is testing

Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy

Who this might be right for
Cancer
Hospital Sirio-Libanes 1,018
Not applicableLooking for participantsNCT06282796
What this trial is testing

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
First Hospital of China Medical University 600
Load More Results